Thyroid cancer patients treated with 131I: radiation dose to relatives after discharge from the hospital.
Thyroid
; 22(1): 59-63, 2012 Jan.
Article
en En
| MEDLINE
| ID: mdl-22136157
ABSTRACT
BACKGROUND:
Thyroid cancer patients treated with radioiodine are potential source of radiation exposure for other individuals. Thus, we evaluated the radiation dose received by family members of thyroid cancer patients treated with (131)I after hospital discharge. MATERIALS ANDMETHODS:
Seventy-six family members of 56 thyroid cancer patients were included in the study. Thyroid cancer patients were given 3.7 GBq of (131)I and remained in a radiation protection ward for 3 days. Radiation protection recommendations were given to patients and relatives. Life conditions were recorded and radiation doses were monitored using a personal dosimeter. RESULTS ANDDISCUSSION:
At discharge, the mean residual activity was 188 MBq. The mean radiation dose delivered to relatives during the 7 days after discharge was low (51.5 µSv) and was similar with either recombinant human thyrotropin (rhTSH) (59 µSv) or withdrawal (50 µSv) (p = 0.37).CONCLUSION:
With our current practice, radiation doses to relatives are low and well below international recommendations.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Contexto en salud:
11_ODS3_cobertura_universal
/
2_ODS3
Problema de salud:
11_delivery_arrangements
/
2_enfermedades_transmissibles
Asunto principal:
Dosis de Radiación
/
Protección Radiológica
/
Neoplasias de la Tiroides
/
Familia
/
Radioisótopos de Yodo
Tipo de estudio:
Guideline
Límite:
Adolescent
/
Adult
/
Aged
/
Child
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Thyroid
Asunto de la revista:
ENDOCRINOLOGIA
Año:
2012
Tipo del documento:
Article
País de afiliación:
Francia